Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

129 Sökresultat.
Relevans Bedömning Nya först Gamla först

Eligibility Diabetes Mellitus, Type 1 NCT00105352

- 2016-08-30 - 1 Formulär, 2 Item-grupper, 12 Dataelement, 1 Språk
Item-grupper: Criteria, Exclusion Criteria
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials; ODM derived from: https://clinicaltrials.gov/show/NCT00105352

Eligibility Diabetes Mellitus, Insulin-Dependent NCT00069628

- 2016-08-29 - 1 Formulär, 1 Item-grupp, 8 Dataelement, 1 Språk
Item-grupp: Inclusion Criteria
Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer; ODM derived from: https://clinicaltrials.gov/show/NCT00069628

Eligibility Diabetes Mellitus, Insulin-Dependent NCT00069615

- 2016-08-29 - 1 Formulär, 2 Item-grupper, 13 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children; ODM derived from: https://clinicaltrials.gov/show/NCT00069615

Eligibility New Onset Type 1 Diabetes Mellitus NCT00214214

- 2016-08-28 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00214214

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - IMD Report - Scleroderma or Morphea; Dermatomyositis or Polymyositis; Diabetes mellitus Type I (Report Final and Annex Report 2 Final)

- 2020-11-02 - 1 Formulär, 25 Item-grupper, 95 Dataelement, 1 Språk
Item-grupper: Administrative, Scleroderma or Morphea, Scleroderma or Morphea - Signs and Symptoms, Scleroderma or Morphea - Other signs and symptoms, Scleroderma or Morphea - Other signs and symptoms , Scleroderma or Morphea - Diagnostic Test Results, Scleroderma or Morphea - Other Diagnostic Test Results , Scleroderma or Morphea - Other Diagnostic Test Results , Scleroderma or Morphea - Other diagnostic Procedure, Dermatomyositis or Polymyositis, Dermatomyositis or Polymyositis - Signs and symptoms (supporting the final diagnosis), Dermatomyositis or Polymyositis - Other Signs and symptoms, Dermatomyositis or Polymyositis - Other Signs and symptoms , Dermatomyositis or Polymyositis - Diagnostic Test Results, Dermatomyositis or Polymyositis - Other Diagnostic Test Results , Dermatomyositis or Polymyositis - Other Diagnostic Test Results , Dermatomyositis or Polymyositis - Other diagnostic Procedure , Diabetes mellitus type I, Diabetes mellitus type I - Signs and symptoms (supporting the final diagnosis), Diabetes mellitus type I - Other Signs and symptoms , Diabetes mellitus type I - Other Signs and symptoms , Diabetes mellitus type I - Diagnostic Test Results , Diabetes mellitus type I - Other Diagnostic Test Results , Diabetes mellitus type I - Other Diagnostic Test Results , Diabetes mellitus type I - Other diagnostic Procedure
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Eligibility Diabetics Mellitus Type 1 NCT01594801

- 2019-11-22 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Testing the Effect of the InsuPad Device in Daily Life Conditions; ODM derived from: https://clinicaltrials.gov/show/NCT01594801

Eligibility Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 NCT02103595

- 2019-11-08 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.; ODM derived from: https://clinicaltrials.gov/show/NCT02103595

Eligibility Patients With Type 1 or Type 2 Diabetes NCT02080741

- 2019-06-11 - 1 Formulär, 2 Item-grupper, 10 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile; ODM derived from: https://clinicaltrials.gov/show/NCT02080741

Eligibility Type 1 Diabetes Mellitus NCT00130481

- 2017-06-29 - 1 Formulär, 2 Item-grupper, 8 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT); ODM derived from: https://clinicaltrials.gov/show/NCT00130481

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial